Two products from Shijiazhuang Sihua Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have been recognized as provincial manufacturing single-champion products.
Category:
Time:2022-12-31

Recently, the Hebei Provincial Department of Industry and Information Technology released the fourth list of provincial manufacturing single-champion enterprises and single-champion products. Both Metronidazole produced by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Siyao Group, and Hydroxyethyl Starch produced by Hebei Guolong Pharmaceutical Co., Ltd. have been recognized as Hebei Province’s manufacturing single-champion products.
In recent years, Shijiazhuang Sihua Pharmaceutical Group has fully leveraged its advantages across the entire industrial chain, strategically aligning innovation chains with the industrial chain. The group has actively promoted the implementation of its “formulation + active pharmaceutical ingredient” development strategy. Its subsidiaries, Guangxiang Pharmaceutical and Guolong Pharmaceutical, have continued to grow and thrive, seamlessly integrating and adopting cutting-edge global technologies and equipment. By strengthening collaboration with research institutes and universities, the group has accelerated the development of specialized, high-value-added APIs, effectively driving optimization and transformation of its product portfolio and empowering the company’s high-quality development.
As a large-scale industrial base for the production, R&D, and export of bulk pharmaceutical ingredients and high-value-added specialty APIs, Guangxiang Pharmaceutical has in recent years focused its research efforts on independent R&D of key specialty APIs and high-end APIs, as well as on breakthrough technological innovations in API synthesis. The company has continuously accelerated its R&D efficiency and stepped up its pace of re-innovating API synthesis technologies, with a strong emphasis on enhancing quality standards. Through continuous process improvements, critical control parameters such as residual solvents, related impurities, and microbial limits in the metronidazole product have steadily improved, reaching internationally leading levels. As a result, the product has been recognized as a quality benchmark in Hebei Province and has spearheaded the development of several national standards. Guangxiang Pharmaceutical’s metronidazole products hold the largest market share within the province and rank among the top in China’s domestic market, enjoying widespread acclaim among downstream customers.
Guided by high-quality development, Guolong Pharmaceutical has integrated the group’s superior resources to tackle key technological challenges, successfully resolving critical issues in product manufacturing processes and breaking through technological bottlenecks that have long hindered industry growth. The company continues to demonstrate strong advantages in the R&D and production of specialty active pharmaceutical ingredients. Its refined, serialized, and high-end API products have garnered widespread attention and recognition from both the industry and society. Among its flagship products, the hydroxyethyl starch series is uniquely produced within the province and ranks among the top sellers in the domestic market.
Keywords:
Recommended
SERVICE HOTLINE
Zip Code: 052165
Address: No.9 Xingye Street, Gaocheng District, Shijiazhuang City, Hebei Province
Mobile site
E code